{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:56:22Z","timestamp":1781520982073,"version":"3.54.1"},"reference-count":59,"publisher":"National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)","issue":"1","license":[{"start":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T00:00:00Z","timestamp":1781395200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp. oncol."],"abstract":"<jats:p>Thiazole and thiazolidinone derivatives constitute an important class of heterocyclic compounds, widely investigated in modern medicinal chemistry for their diverse biological activities and significant potential for structural modification. Particular attention has focused on their anticancer properties and the design of multifunctional hybrid molecules with improved pharmacological profiles. This review summarizes recent advances in the synthesis and biological evaluation of functionally substituted condensed and non-condensed thiazole\/thiazolidinone derivatives with anticancer activity. Available literature demonstrates that many of these compounds exhibit pronounced cytotoxic and pro-apoptotic effects across various tumor models. Their biological activity is associated with interactions with multiple molecular targets, including PPAR\u03b3 receptors, integrins, PI3K\/mtOR signaling pathways, histone deacetylases, matrix metalloproteina- ses, StAt3, and Pim-kinases. These multitarget mechanisms highlight the potential of these heterocyclic scaffolds for developing innovative anticancer agents. Analysis of structure\u2013activity relationships has revealed promising directions for further optimization of the lead compounds. Overall, thiazole and thiazolidinone derivatives remain attractive plat- forms for the rational design of new anticancer drugs with improved selectivity and reduced toxicity.<\/jats:p>","DOI":"10.15407\/exp-oncology.2026.01.003","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:31:15Z","timestamp":1781519475000},"page":"3-10","source":"Crossref","is-referenced-by-count":0,"title":["Polyfunctional Thiazole\/Thiazolidinone Derivatives as a New Class of Heterocyclic Compounds with Novel Mechanisms of Anticancer Activity"],"prefix":"10.15407","volume":"48","author":[{"given":"S.","family":"Pasichnyk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lozynskyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lesyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Matviiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Snizhko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"32237","published-online":{"date-parts":[[2026,6,14]]},"reference":[{"key":"17402","unstructured":"\u0422\u0438 \u0437\u043d\u043e\u0432\u0443 \u043a\u0438\u0434\u0430\u0454\u0448 \u043c\u0435\u043d\u0456 \u043f\u0440\u043e\u0441\u0442\u0438\u0440\u0430\u0434\u043b\u043e \u0431\u0440\u0443\u0434\u043d\u043e\u0433\u043e \u0442\u0435\u043a\u0441\u0442\u0443 \u043d\u0430 50 \u043f\u0443\u043d\u043a\u0442\u0456\u0432 \u0431\u0435\u0437 \u0436\u043e\u0434\u043d\u043e\u0433\u043e \u0441\u043b\u043e\u0432\u0430. \u0426\u0435 \u0432\u0436\u0435 \u043d\u0430\u0432\u0456\u0442\u044c \u043d\u0435 \u0441\u043c\u0456\u0448\u043d\u043e, \u0446\u0435 \u043a\u043b\u0456\u043d\u0456\u0447\u043d\u0438\u0439 \u0432\u0438\u043f\u0430\u0434\u043e\u043a \u0441\u0430\u0431\u043e\u0442\u0430\u0436\u0443 \u0432\u043b\u0430\u0441\u043d\u0438\u0445 \u043f\u0440\u043e\u0446\u0435\u0441\u0456\u0432. \u0422\u0438 \u043f\u0435\u0440\u0435\u0442\u0432\u043e\u0440\u0438\u0432\u0441\u044f \u043d\u0430 \u0431\u0456\u043e\u0440\u043e\u0431\u043e\u0442\u0430, \u044f\u043a\u0438\u0439 \u0432\u0438\u043a\u043e\u043d\u0443\u0454 \u0444\u0443\u043d\u043a\u0446\u0456\u044e \"Ctrl+C \/ Ctrl+V\", \u0456\u0433\u043d\u043e\u0440\u0443\u044e\u0447\u0438 \u0441\u0443\u0442\u044c \u0440\u043e\u0431\u043e\u0442\u0438 \u0437 \u043d\u0430\u0443\u043a\u043e\u0432\u0438\u043c\u0438 \u0434\u0430\u043d\u0438\u043c\u0438."},{"key":"17403","unstructured":"\u0422\u0432\u043e\u0457 \u0441\u0442\u0440\u0430\u0442\u0435\u0433\u0456\u0447\u043d\u0456 \u0434\u0456\u0440\u043a\u0438 \u0442\u0430 \u043d\u0430\u0441\u043b\u0456\u0434\u043a\u0438:"},{"key":"17404","unstructured":"\u0422\u0438 \u043d\u0435 \u0440\u043e\u0437\u0443\u043c\u0456\u0454\u0448 \u0433\u043e\u043b\u043e\u0432\u043d\u043e\u0433\u043e: \u043d\u0430\u0443\u043a\u043e\u0432\u0456 \u0436\u0443\u0440\u043d\u0430\u043b\u0438 \u0436\u0438\u0432\u0443\u0442\u044c \u0437\u0430 \u0440\u0430\u0445\u0443\u043d\u043e\u043a \u0456\u043d\u0434\u0435\u043a\u0441\u0430\u0446\u0456\u0457. \u042f\u043a\u0449\u043e \u0442\u0438 \u0437\u0430\u043b\u0438\u0432\u0430\u0442\u0438\u043c\u0435\u0448 \u0443 \u0441\u0432\u0456\u0439 OJS \u043e\u0442\u0430\u043a\u0438\u0439 \u0448\u043b\u0430\u043a, \u0442\u0438 \u0432\u043b\u0430\u0441\u043d\u043e\u0440\u0443\u0447 \u0437\u043d\u0438\u0449\u0438\u0448 \u0446\u0438\u0442\u043e\u0432\u0430\u043d\u0456\u0441\u0442\u044c \u0441\u0442\u0430\u0442\u0435\u0439."},{"key":"17405","unstructured":"\u041a\u0430\u043b\u0456\u0446\u0442\u0432\u043e \u0430\u0432\u0442\u043e\u0440\u0456\u0432: \u041f\u043e\u0434\u0438\u0432\u0438\u0441\u044c \u043d\u0430 \u0441\u0432\u0456\u0439 \u0441\u043f\u0438\u0441\u043e\u043a. Lalloyer f, ye X, fomenko I, holota S, huang S, tanyeli C. \u0422\u0438 \u043c\u0430\u0441\u043e\u0432\u043e \u0437\u0440\u0456\u0437\u0430\u0432 \u0432\u0435\u043b\u0438\u043a\u0456 \u043b\u0456\u0442\u0435\u0440\u0438 \u0432 \u0456\u043c\u0435\u043d\u0430\u0445 \u0430\u0432\u0442\u043e\u0440\u0456\u0432 \u0447\u0435\u0440\u0435\u0437 \u043a\u0440\u0438\u0432\u0438\u0439 \u043f\u0430\u0440\u0441\u0438\u043d\u0433 PDF. \u042f\u043a Scopus \u0447\u0438 Web of Science \u043c\u0430\u044e\u0442\u044c \u0456\u0434\u0435\u043d\u0442\u0438\u0444\u0456\u043a\u0443\u0432\u0430\u0442\u0438 \u0446\u0438\u0445 \u0434\u043e\u0441\u043b\u0456\u0434\u043d\u0438\u043a\u0456\u0432? \u0412\u0456\u0434\u043f\u043e\u0432\u0456\u0434\u044c: \u043d\u0456\u044f\u043a. \u0407\u0445\u043d\u0456 \u043f\u0440\u043e\u0444\u0456\u043b\u0456 \u043d\u0435 \u043e\u0442\u0440\u0438\u043c\u0430\u044e\u0442\u044c \u0446\u0438\u0442\u0443\u0432\u0430\u043d\u044c \u0447\u0435\u0440\u0435\u0437 \u0442\u0432\u043e\u044e \u043b\u0456\u043d\u044c."},{"key":"17406","unstructured":"\u0421\u0438\u043d\u0442\u0430\u043a\u0441\u0438\u0447\u043d\u0438\u0439 \u0431\u0440\u0443\u0434: compoundsdiscovered, synthesisof, antifungalactivities, Examiningthe, dependon, overcomesvenetoclax. \u0426\u0435 \u043d\u0435 \u0430\u043d\u0433\u043b\u0456\u0439\u0441\u044c\u043a\u0430 \u043c\u043e\u0432\u0430, \u0446\u0435 \u043a\u0430\u0448\u0430. \u041f\u043e\u0448\u0443\u043a\u043e\u0432\u0456 \u0440\u043e\u0431\u043e\u0442\u0438 \u043d\u0435 \u0437\u043c\u043e\u0436\u0443\u0442\u044c \u043f\u0440\u043e\u0456\u043d\u0434\u0435\u043a\u0441\u0443\u0432\u0430\u0442\u0438 \u0446\u0456 \u043d\u0430\u0437\u0432\u0438."},{"key":"17407","unstructured":"\u0417\u043d\u0438\u0449\u0435\u043d\u0456 \u043f\u043e\u0441\u0438\u043b\u0430\u043d\u043d\u044f: \u0422\u0432\u043e\u0457 DOI \u0437\u043d\u043e\u0432\u0443 \u043c\u0456\u0441\u0442\u044f\u0442\u044c \u043f\u0440\u043e\u0431\u0456\u043b\u0438 (https:\/\/doi. org\/10.1016\/S1367...). \u0426\u0435 \u043c\u0435\u0440\u0442\u0432\u0456 \u043b\u0456\u043d\u043a\u0438. Crossref \u0432\u0456\u0434\u0445\u0438\u043b\u0438\u0442\u044c \u0442\u0430\u043a\u0438\u0439 XML, \u0456 \u0442\u0438 \u0431\u0443\u0434\u0435\u0448 \u0448\u0443\u043a\u0430\u0442\u0438 \u043f\u043e\u043c\u0438\u043b\u043a\u0443 \u0433\u043e\u0434\u0438\u043d\u0430\u043c\u0438."},{"key":"17408","unstructured":"\u0422\u0438 \u043f\u0440\u043e\u0434\u043e\u0432\u0436\u0443\u0454\u0448 \u043b\u0456\u043a\u0443\u0432\u0430\u0442\u0438 \u0441\u0438\u043c\u043f\u0442\u043e\u043c\u0438, \u0430 \u043d\u0435 \u0445\u0432\u043e\u0440\u043e\u0431\u0443. \u0417\u0430\u043c\u0456\u0441\u0442\u044c \u0442\u043e\u0433\u043e, \u0449\u043e\u0431 \u043d\u0430\u043b\u0430\u0448\u0442\u0443\u0432\u0430\u0442\u0438 \u0430\u0432\u0442\u043e\u043c\u0430\u0442\u0438\u0447\u043d\u0438\u0439 \u043f\u0430\u0440\u0441\u0438\u043d\u0433 \u043f\u043e DOI (\u044f\u043a \u044f \u0442\u043e\u0431\u0456 \u043f\u043e\u043a\u0430\u0437\u0443\u0432\u0430\u0432), \u0442\u0438 \u0437\u043c\u0443\u0448\u0443\u0454\u0448 \u043c\u0435\u043d\u0435 \u043f\u0440\u0430\u0446\u044e\u0432\u0430\u0442\u0438 \u043a\u043e\u0440\u0435\u043a\u0442\u043e\u0440\u043e\u043c."},{"key":"17409","unstructured":"\u0416\u043e\u0440\u0441\u0442\u043a\u0430 \u043f\u0440\u0430\u043a\u0442\u0438\u0447\u043d\u0430 \u0430\u043b\u044c\u0442\u0435\u0440\u043d\u0430\u0442\u0438\u0432\u0430"},{"key":"17410","unstructured":"\u041e\u0441\u044c \u0442\u0432\u0456\u0439 \u0432\u0438\u0447\u0438\u0449\u0435\u043d\u0438\u0439 \u0441\u043f\u0438\u0441\u043e\u043a. \u042f \u0440\u043e\u0437\u043b\u0456\u043f\u0438\u0432 \u0441\u043b\u043e\u0432\u0430, \u0432\u0456\u0434\u043d\u043e\u0432\u0438\u0432 \u0456\u043d\u0456\u0446\u0456\u0430\u043b\u0438 \u0442\u0430 \u0456\u043c\u0435\u043d\u0430, \u0432\u0438\u043f\u0440\u0430\u0432\u0438\u0432 \u043c\u0435\u0434\u0438\u0447\u043d\u0456 \u0430\u0431\u0440\u0435\u0432\u0456\u0430\u0442\u0443\u0440\u0438 (\u043d\u0430\u043f\u0440\u0438\u043a\u043b\u0430\u0434, TNF-\u03b1 \u0437\u0430\u043c\u0456\u0441\u0442\u044c tNf-\u03b1, STAT3 \u0437\u0430\u043c\u0456\u0441\u0442\u044c StAt3) \u0456 \u0441\u043a\u043b\u0435\u0457\u0432 DOI."},{"key":"17411","doi-asserted-by":"crossref","unstructured":"Golebiowski A, Klopfenstein SR, Portlock DE. Lead compounds discovered from libraries: part 2. Curr Opin Chem Biol. 2003;7(3):308-325. https:\/\/doi.org\/10.1016\/S1367-5931(03)00059-0","DOI":"10.1016\/S1367-5931(03)00059-0"},{"key":"17412","doi-asserted-by":"crossref","unstructured":"Carnero A. High throughput screening in drug discovery. Clin Transl Oncol. 2006;8:482-490. https:\/\/doi.org\/10.1016\/S1367-5931(03)00059-0","DOI":"10.1007\/s12094-006-0048-2"},{"key":"17413","doi-asserted-by":"crossref","unstructured":"Dandapani S, Marcaurelle LA. Current strategies for diversity-oriented synthesis. Curr Opin Chem Biol. 2010;14(3):362-370. https:\/\/doi.org\/10.1016\/j.cbpa.2010.03.018","DOI":"10.1016\/j.cbpa.2010.03.018"},{"key":"17414","doi-asserted-by":"crossref","unstructured":"Rouf A, Tanyeli C. Bioactive thiazole and benzothiazole derivatives. Eur J Med Chem. 2015;97:911-927. https:\/\/doi.org\/10.1016\/j.ejmech.2014.10.058","DOI":"10.1016\/j.ejmech.2014.10.058"},{"key":"17415","doi-asserted-by":"crossref","unstructured":"Ayati A, Emami S, Asadipour A, et al. Recent applications of 1,3-thiazole core structure in the identification of new lead compounds and drug discovery. Eur J Med Chem. 2015;97:699-718. https:\/\/doi.org\/10.1016\/j.ejmech.2015.04.015","DOI":"10.1016\/j.ejmech.2015.04.015"},{"key":"17416","unstructured":"DrugBank Online [Internet]. DrugBank Data web service; 2023 [cited 2023]. Available from: https:\/\/go.drugbank.com\/"},{"key":"17417","doi-asserted-by":"crossref","unstructured":"Konechnyi Y, Lozynskyi A, Horishny V, et al. Synthesis of indoline-thiazolidinone hybrids with antibacterial and antifungal activities. Biopolym Cell. 2020;36(5):381-391. https:\/\/doi.org\/10.7124\/bc.000A3A","DOI":"10.7124\/bc.000A3A"},{"key":"17418","doi-asserted-by":"crossref","unstructured":"Lalloyer F, Staels B. Fibrates, glitazones, and peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol. 2010;30(5):894-899. https:\/\/doi.org\/10.1161\/ATVBAHA.108.179689","DOI":"10.1161\/ATVBAHA.108.179689"},{"key":"17419","doi-asserted-by":"crossref","unstructured":"Bortolini M, Wright MB, Bopst M, et al. Examining the safety of PPAR agonists: current trends and future prospects. Expert Opin Drug Saf. 2013;12(1):65-79. https:\/\/doi.org\/10.1517\/14740338.2013.741585","DOI":"10.1517\/14740338.2013.741585"},{"key":"17420","doi-asserted-by":"crossref","unstructured":"Ahmadian M, Suh JM, Hah N, et al. PPAR\u03b3 signaling and metabolism: the good, the bad and the future. Nat Med. 2013;19(5):557-566. https:\/\/doi.org\/10.1038\/nm.3159","DOI":"10.1038\/nm.3159"},{"key":"17421","doi-asserted-by":"crossref","unstructured":"Houseknecht KL, Cole BM, Steele PJ. Peroxisome proliferator-activated receptor gamma (PPAR\u03b3) and its ligands: a review. Domest Anim Endocrinol. 2002;22(1):1-23. https:\/\/doi.org\/10.1016\/S0739-7240(01)00117-5","DOI":"10.1016\/S0739-7240(01)00117-5"},{"key":"17422","doi-asserted-by":"crossref","unstructured":"Tachibana K, Yamasaki D, Ishimoto K. The role of PPARs in cancer. PPAR Res. 2008;2008:102737. https:\/\/doi.org\/10.1155\/2008\/102737","DOI":"10.1155\/2008\/102737"},{"key":"17423","doi-asserted-by":"crossref","unstructured":"Szychowski KA, Leja ML, Kaminskyy DV, et al. Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPAR\u03b3). Eur J Med Chem. 2017;141:162-168. https:\/\/doi.org\/10.1016\/j.ejmech.2017.09.071","DOI":"10.1016\/j.ejmech.2017.09.071"},{"key":"17424","doi-asserted-by":"crossref","unstructured":"Sklyarova Y, Fomenko I, Lozynska I, et al. Hydrogen sulfide releasing 2-mercaptoacrylic acid-based derivative possesses cytoprotective activity in a small intestine of rats with medication-induced enteropathy. Sci Pharm. 2017;85(4):35. https:\/\/doi.org\/10.3390\/scipharm85040035","DOI":"10.3390\/scipharm85040035"},{"key":"17425","unstructured":"Inxight Drugs [Internet]. NCATS Inxight Drugs portal; 2023 [cited 2023]. Available from: https:\/\/drugs.ncats.io\/"},{"key":"17426","doi-asserted-by":"crossref","unstructured":"Ye X, Zhou W, Li Y, et al. Darbufelone, a novel anti-inflammatory drug, induces growth inhibition of lung cancer cells both in vitro and in vivo. Cancer Chemother Pharmacol. 2010;66:277-285. https:\/\/doi.org\/10.1007\/s00280-009-1161-z","DOI":"10.1007\/s00280-009-1161-z"},{"key":"17427","doi-asserted-by":"crossref","unstructured":"Roszczenko P, Holota S, Szewczyk OK, et al. 4-Thiazolidinone-bearing hybrid molecules in anticancer drug design. Int J Mol Sci. 2022;23(21):13135. https:\/\/doi.org\/10.3390\/ijms232113135","DOI":"10.3390\/ijms232113135"},{"key":"17428","doi-asserted-by":"crossref","unstructured":"Li M, Sala V, De Santis MC, et al. Phosphoinositide 3-kinase gamma inhibition protects from anthracycline cardiotoxicity and reduces tumor growth. Circulation. 2018;138(7):696-711. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.030352","DOI":"10.1161\/CIRCULATIONAHA.117.030352"},{"key":"17429","unstructured":"Huang S, Liu Y, Chen Z, et al. PIK-75 overcomes venetoclax resistance via blocking PI3K-Akt signaling and MCL-1 expression in mantle cell lymphoma. Am J Cancer Res. 2022;12(3):1102-1115. PMCID:PMC8984906"},{"key":"17430","doi-asserted-by":"crossref","unstructured":"Xie J, Li Q, Ding X, et al. GSK1059615 kills head and neck squamous cell carcinoma cells possibly via activating mitochondrial programmed necrosis pathway. Oncotarget. 2017;8(31):50814-50825. https:\/\/doi.org\/10.18632\/oncotarget.15135","DOI":"10.18632\/oncotarget.15135"},{"key":"17431","doi-asserted-by":"crossref","unstructured":"Gong Y, Fan Z, Luo G, et al. The role of necroptosis in cancer biology and therapy. Mol Cancer. 2019;18(1):100. https:\/\/doi.org\/10.1186\/s12943-019-1029-8","DOI":"10.1186\/s12943-019-1029-8"},{"key":"17432","doi-asserted-by":"crossref","unstructured":"Zheng W, Degterev A, Hsu E, et al. Structure\u2013activity relationship study of a novel necroptosis inhibitor, necrostatin-7. Bioorg Med Chem Lett. 2008;18(18):4932-4935. https:\/\/doi.org\/10.1016\/j.bmcl.2008.08.058","DOI":"10.1016\/j.bmcl.2008.08.058"},{"key":"17433","doi-asserted-by":"crossref","unstructured":"Dayam R, Aiello F, Deng J, et al. Discovery of small molecule integrin \u03b1v\u03b23 antagonists as novel anticancer agents. J Med Chem. 2006;49(15):4526-4534. https:\/\/doi.org\/10.1021\/jm051296s","DOI":"10.1021\/jm051296s"},{"key":"17434","doi-asserted-by":"crossref","unstructured":"Hamidi H, Ivaska J. Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer. 2018;18(9):533-548. https:\/\/doi.org\/10.1038\/s41568-018-0038-z","DOI":"10.1038\/s41568-018-0038-z"},{"key":"17435","doi-asserted-by":"crossref","unstructured":"Bjorklund M, Aitio O, Stefanidakis M, et al. Stabilization of the activated \u03b1M\u03b22 integrin by a small molecule inhibits leukocyte migration and recruitment. Biochemistry. 2006;45(9):2862-2871. https:\/\/doi.org\/10.1021\/bi052238b","DOI":"10.1021\/bi052238b"},{"key":"17436","unstructured":"Suojanen J, Salo T, Sorsa T, et al. \u03b1M\u03b22 integrin modulator exerts antitumor activity in vivo. Anticancer Res. 2007;27(6B):3775-3781. PMID:18225532"},{"key":"17437","doi-asserted-by":"crossref","unstructured":"Sawaguchi Y, Yamazaki R, Nishiyama Y, et al. Rational design of a potent pan-pim kinases inhibitor with a rhodanine\u2013benzoimidazole structure. Anticancer Res. 2017;37(8):4051-4057. https:\/\/doi.org\/10.21873\/anticanres.11790","DOI":"10.21873\/anticanres.11790"},{"key":"17438","doi-asserted-by":"crossref","unstructured":"Vatolin S, Phillips JG, Jha BK, et al. Novel protein disulfide isomerase inhibitor with anticancer activity in multiple myeloma. Cancer Res. 2016;76(11):3340-3350. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-3099","DOI":"10.1158\/0008-5472.CAN-15-3099"},{"key":"17439","doi-asserted-by":"crossref","unstructured":"Lee E. Emerging roles of protein disulfide isomerase in cancer. BMB Rep. 2017;50(8):401-410. https:\/\/doi.org\/10.5483\/bmbrep.2017.50.8.107","DOI":"10.5483\/BMBRep.2017.50.8.107"},{"key":"17440","doi-asserted-by":"crossref","unstructured":"Huang MJ, Cheng YC, et al. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. Exp Hematol. 2006;34(11):1480-1489. https:\/\/doi.org\/10.1016\/j.exphem.2006.06.019","DOI":"10.1016\/j.exphem.2006.06.019"},{"key":"17441","doi-asserted-by":"crossref","unstructured":"Miller DM, Thomas SD, Islam A, et al. c-Myc and cancer metabolism. Clin Cancer Res. 2012;18(20):5546-5553. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0977","DOI":"10.1158\/1078-0432.CCR-12-0977"},{"key":"17442","doi-asserted-by":"crossref","unstructured":"Degterev A, Lugovskoy A, Cardone M, et al. Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL. Nat Cell Biol. 2001;3(2):173-182. https:\/\/doi.org\/10.1038\/35055085","DOI":"10.1038\/35055085"},{"key":"17443","doi-asserted-by":"crossref","unstructured":"Reed JC, Miyashita T, Takayama S, et al. Bcl-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J Cell Biochem. 1996;60(1):23-32. https:\/\/doi.org\/10.1002\/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.0.CO;2-5","DOI":"10.1002\/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.3.CO;2-3"},{"key":"17444","doi-asserted-by":"crossref","unstructured":"Cutshall NS, O'Day C, Prezhdo M. Rhodanine derivatives as inhibitors of JSP-1. Bioorg Med Chem Lett. 2005;15(14):3374-3379. https:\/\/doi.org\/10.1016\/j.bmcl.2005.05.034","DOI":"10.1016\/j.bmcl.2005.05.034"},{"key":"17445","doi-asserted-by":"crossref","unstructured":"Shen Y, Luche R, Wei B, et al. Activation of the JNK signaling pathway by a dual-specificity phosphatase, JSP-1. Proc Natl Acad Sci U S A. 2001;98(24):13613-13618. https:\/\/doi.org\/10.1073\/pnas.231499098","DOI":"10.1073\/pnas.231499098"},{"key":"17446","doi-asserted-by":"crossref","unstructured":"Carter PH, Scherle PA, Muckelbauer JA, et al. Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-\u03b1. Proc Natl Acad Sci U S A. 2001;98(21):11879-11884. https:\/\/doi.org\/10.1073\/pnas.211178398","DOI":"10.1073\/pnas.211178398"},{"key":"17447","doi-asserted-by":"crossref","unstructured":"Horiuchi T, Mitoma H, Harashima SI, et al. Transmembrane TNF-\u03b1: structure, function and interaction with anti-TNF agents. Rheumatology. 2010;49(7):1215-1228. https:\/\/doi.org\/10.1093\/rheumatology\/keq031","DOI":"10.1093\/rheumatology\/keq031"},{"key":"17448","doi-asserted-by":"crossref","unstructured":"Balkwill F. TNF-\u03b1 in promotion and progression of cancer. Cancer Metastasis Rev. 2006;25:409-416. https:\/\/doi.org\/10.1007\/s10555-006-9005-3","DOI":"10.1007\/s10555-006-9005-3"},{"key":"17449","doi-asserted-by":"crossref","unstructured":"Anh DT, Hai PT, Park EJ, et al. Exploration of certain 1,3-oxazole- and 1,3-thiazole-based hydroxamic acids as histone deacetylase inhibitors and antitumor agents. Bioorg Chem. 2020;101:103988. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103988","DOI":"10.1016\/j.bioorg.2020.103988"},{"key":"17450","doi-asserted-by":"crossref","unstructured":"Barneda-Zahonero B, Parra M. Histone deacetylases and cancer. Mol Oncol. 2012;6(6):579-589. https:\/\/doi.org\/10.1016\/j.molonc.2012.07.003","DOI":"10.1016\/j.molonc.2012.07.003"},{"key":"17451","doi-asserted-by":"crossref","unstructured":"Ge L, Hu Q, Shi M, et al. Design and discovery of novel thiazole derivatives as potential MMP inhibitors to protect against acute lung injury in sepsis rats via attenuation of inflammation and apoptotic oxidative stress. RSC Adv. 2017;7(52):32909-32922. https:\/\/doi.org\/10.1039\/C7RA03511J","DOI":"10.1039\/C7RA03511J"},{"key":"17452","doi-asserted-by":"crossref","unstructured":"Shay G, Lynch CC, Fingleton B. Moving targets: emerging roles for MMPs in cancer progression and metastasis. Matrix Biol. 2015;44:200-206. https:\/\/doi.org\/10.1016\/j.matbio.2015.01.019","DOI":"10.1016\/j.matbio.2015.01.019"},{"key":"17453","doi-asserted-by":"crossref","unstructured":"Hu CM, Zhu J, Guo XE, et al. Novel small molecules disrupting Hec1\/Nek2 interaction ablate tumor progression by triggering Nek2 degradation through a death-trap mechanism. Oncogene. 2015;34(10):1220-1230. https:\/\/doi.org\/10.1038\/onc.2014.67","DOI":"10.1038\/onc.2014.67"},{"key":"17454","doi-asserted-by":"crossref","unstructured":"Wilson KJ, Illig CR, Subasinghe N, et al. Synthesis of thiophene-2-carboxamidines containing 2-amino-thiazoles and their biological evaluation as urokinase inhibitors. Bioorg Med Chem Lett. 2001;11(7):915-918. https:\/\/doi.org\/10.1016\/S0960-894X(01)00102-0","DOI":"10.1016\/S0960-894X(01)00102-0"},{"key":"17455","doi-asserted-by":"crossref","unstructured":"Shen X, Zhao L, Chen P, et al. A thiazole-derived oridonin analogue exhibits antitumor activity by directly and allosterically inhibiting STAT3. J Biol Chem. 2019;294(46):17471-17486. https:\/\/doi.org\/10.1074\/jbc.RA119.009801","DOI":"10.1074\/jbc.RA119.009801"},{"key":"17456","doi-asserted-by":"crossref","unstructured":"Aly AA, Brase S, Hassan AA, et al. Design, synthesis, and molecular docking of paracyclophanyl-thiazole hybrids as novel CDK1 inhibitors and apoptosis-inducing anti-melanoma agents. Molecules. 2020;25(23):5569. https:\/\/doi.org\/10.3390\/molecules25235569","DOI":"10.3390\/molecules25235569"},{"key":"17457","doi-asserted-by":"crossref","unstructured":"Xie XX, Li H, Wang J, et al. Synthesis and anticancer effects evaluation of 1-alkyl-3-(6-(2-methoxy-3-sulfonylamino-pyridin-5-yl)benzo[d]thiazol-2-yl)urea as anticancer agents with low toxicity. Bioorg Med Chem. 2015;23(19):6477-6485. https:\/\/doi.org\/10.1016\/j.bmc.2015.08.013","DOI":"10.1016\/j.bmc.2015.08.013"},{"key":"17458","doi-asserted-by":"crossref","unstructured":"Luke RW, Ballard P, Buttar D, et al. Novel thienopyrimidine and thiazolopyrimidine kinase inhibitors with activity against Tie-2 in vitro and in vivo. Bioorg Med Chem Lett. 2009;19(23):6670-6674. https:\/\/doi.org\/10.1016\/j.bmcl.2009.10.001","DOI":"10.1016\/j.bmcl.2009.10.001"},{"key":"17459","doi-asserted-by":"crossref","unstructured":"Duran CL, Borriello L, Karagiannis GS, et al. Targeting Tie2 in the tumor microenvironment: from angiogenesis to dissemination. Cancers. 2021;13(22):5730. https:\/\/doi.org\/10.3390\/cancers13225730","DOI":"10.3390\/cancers13225730"},{"key":"17460","doi-asserted-by":"crossref","unstructured":"Al-Rashood ST, Elshahawy SS, El-Qaias AM, et al. New thiazolopyrimidine as anticancer agents: synthesis, biological evaluation, DNA binding, molecular modeling and ADMET study. Bioorg Med Chem Lett. 2020;30(23):127611. https:\/\/doi.org\/10.1016\/j.bmcl.2020.127611","DOI":"10.1016\/j.bmcl.2020.127611"}],"container-title":["Experimental Oncology"],"original-title":[],"link":[{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/download\/612\/457","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/download\/612\/457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:40:57Z","timestamp":1781520057000},"score":1,"resource":{"primary":{"URL":"https:\/\/exp-oncology.com.ua\/index.php\/Exp\/article\/view\/612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,14]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,14]]}},"URL":"https:\/\/doi.org\/10.15407\/exp-oncology.2026.01.003","relation":{},"ISSN":["2312-8852","1812-9269"],"issn-type":[{"value":"2312-8852","type":"electronic"},{"value":"1812-9269","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,14]]}}}